SIRT3 and movement disorder: Moreover, there was no difference in the SIRT3 activity or its expression in patients with movement disorders related to synucleinopathy (66.8; 41.9–111.8 U/μg protein and 35.5; 23.1–58.7 μg/mg protein) compared with patients without synucleinopathy (104.8; 30.9–146.2 U/μg protein; median, interquartile range, P = 0.6652 and 36.6; 28.5–57.7 μg/mg protein, median, interquartile range, P = 0.7913).